Related Experiment Video
Updated: Sep 13, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Multiple presentations of drug-resistant central nervous system tuberculosis: a case report
1Department of Infectious Diseases, Faculty of Medicine, Infectious Diseases Research Center, Aja University of Medical Sciences, Tehran, Iran.
Introduction And Importance:
Central nervous system tuberculosis (CNS-TB) is a severe manifestation of Mycobacterium tuberculosis infection that can cause substantial morbidity and mortality. Tuberculous ventriculitis and intramedullary tuberculoma are two rare complications, and their coexistence poses significant diagnostic and therapeutic challenges.
Case Presentation:
A 19-year-old woman with a history of systemic lupus erythematosus, treated with prednisolone and methotrexate for the past 2 years, was diagnosed with isoniazid-resistant tuberculous meningitis and multiple intracranial tuberculomas. After 4 weeks of antitubercular treatment (ATT), she experienced progressive quadriparesis, lethargy, seizures, and fever. Brain and cervical spine MRI revealed tuberculous ventriculitis and a C3-C5 intramedullary tuberculoma. The ATT led to a paradoxical neurological decline and the emergence of new lesions, consistent with tuberculous immune reconstitution inflammatory syndrome (TB-IRIS). Additionally, electrodiagnostic studies indicated the possibility of Guillain-Barré syndrome (GBS). She was referred for cervical spinal cord decompression while continuing isoniazid-sparing ATT and high-dose corticosteroids. Her neurological condition improved, and a follow-up MRI conducted 2 years later showed radiologic resolution.
Clinical Discussion:
This case underscores the diagnostic challenges of CNS-TB in an immunocompromised patient, particularly when TB-IRIS, ventriculitis, intramedullary tuberculoma, and GBS co-occur. A positive outcome required timely identification of paradoxical worsening and immunological reactions, meticulous exclusion of alternative diagnoses, and integrated medical and surgical interventions.
Conclusion:
The emergence of new neurological lesions after the initiation of ATT in patients with CNS-TB, especially those receiving immunosuppressive therapy, necessitates consideration of TB-IRIS. Prompt imaging, evaluation of alternative diagnoses, and interdisciplinary management may improve outcomes.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Cryptococcal Meningitis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
